Pedro Perdigão
Universidade de Coimbra
H-index: 5
Europe-Portugal
Top articles of Pedro Perdigão
A Novel Genetic Variant in MBD5 Associated with Severe Epilepsy and Intellectual Disability: Potential Implications on Neural Primary Cilia
International Journal of Molecular Sciences
2023/8/9
Pedro Perdigão
H-Index: 2
João Peça
H-Index: 12
CRISPR-Cas9 correction of a nonsense mutation in LCA5 rescues lebercilin expression and localization in human retinal organoids
Molecular Therapy-Methods & Clinical Development
2023/6/8
Extracellular communication between brain cells through functional transfer of Cre mRNA mediated by extracellular vesicles
Molecular Therapy
2023/5/16
Retinal Organoids from an AIPL1 CRISPR/Cas9 Knockout Cell Line Successfully Recapitulate the Molecular Features of LCA4 Disease
International Journal of Molecular Sciences
2023/3/21
Induced pluripotent stem cells and genome-editing tools in determining gene function and therapy for inherited retinal disorders
2022/12/3
Insomnia patient-derived iPSC neurons with potential for disease modeling
Sleep Medicine
2022/12/1
Investigation of PTC124-mediated translational readthrough in a retinal organoid model of AIPL1-associated Leber congenital amaurosis
Stem Cell Reports
2022/10/11
CRISPR-Cas9 correction of OPA1 c. 1334G> A: p. R445H restores mitochondrial homeostasis in dominant optic atrophy patient-derived iPSCs
Molecular Therapy-Nucleic Acids
2021/12/3
Investigation of Ataluren (PTC124) as a potential therapeutic for LCA4 in a patient-derived iPS-retinal organoid model
Investigative Ophthalmology & Visual Science
2021/6/21
Translational readthrough as a potential therapeutic for AIPL1-associated Leber Congenital Amaurosis in a patient-derived iPSC-retinal organoid model
bioRxiv
2021/12/18
Protein Delivery of Cell-Penetrating Zinc-Finger Activators Stimulates Latent HIV-1-Infected Cells
Molecular Therapy-Methods & Clinical Development
2020/9/11
Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody
Cellular and Molecular Life Sciences
2020/7
